FLOW CYTOMETRY, CD 25

The Flow Cytometry CD25 Test is a specialized immunophenotyping assay used to detect and measure the expression of CD25, also known as the Interleukin-2 Receptor Alpha Chain (IL-2Rα), on the surface of immune cells. CD25 is an important marker involved in immune regulation and lymphocyte activation.

CD25 is normally expressed on activated T lymphocytes, regulatory T cells (Tregs), and certain other immune cells. Abnormal expression of CD25 may be associated with various hematological malignancies, immune system disorders, and lymphoproliferative diseases. Therefore, CD25 analysis is frequently included in comprehensive flow cytometry panels used for diagnosing and classifying blood cancers and immune-related conditions.

Flow cytometry technology enables rapid analysis of thousands of cells individually, providing accurate information about CD25-positive cell populations and their characteristics. The test is commonly performed on peripheral blood, bone marrow aspirates, lymph node specimens, or other relevant clinical samples.

Benefits of the Test

• Detects and measures CD25 expression
• Assists in leukemia and lymphoma diagnosis
• Supports immunophenotyping of abnormal lymphocytes
• Helps evaluate immune system disorders
• Assists in disease classification and monitoring
• Provides valuable diagnostic and prognostic information

Why Doctors Recommend This Test

Doctors may recommend Flow Cytometry CD25 testing for:

• Suspected leukemia
• Suspected lymphoma
• Adult T-cell leukemia/lymphoma evaluation
• Hairy cell leukemia investigation
• Lymphoproliferative disorder assessment
• Immune dysregulation disorders
• Monitoring hematological malignancies
• Comprehensive immunophenotyping studies

The test helps identify abnormal immune cell populations and contributes to accurate disease classification.

Preparation Before Test

The test may require:

• Peripheral blood sample
• Bone marrow aspirate
• Lymph node specimen
• Other clinically appropriate samples

Preparation generally includes:

• No fasting is usually required
• Inform your doctor about ongoing treatments
• Follow laboratory instructions regarding specimen collection

The procedure involves standard sample collection and laboratory analysis.

Normal Reporting Time

Results are generally available within 1 to 3 working days, depending on the complexity of the flow cytometry panel.

Who Should Take This Test?

• Patients with suspected leukemia or lymphoma
• Individuals with abnormal blood counts
• Patients undergoing hematological evaluation
• Individuals with suspected lymphoproliferative disorders
• Patients requiring immunophenotyping studies
• Individuals referred by hematologists or oncologists

The Flow Cytometry CD25 Test is an important component of advanced hematology and immunology diagnostics.

Clinical Significance

CD25 expression may be seen in:

• Activated T lymphocytes
• Regulatory T cells (Tregs)
• Adult T-cell leukemia/lymphoma
• Hairy Cell Leukemia
• Certain lymphomas
• Lymphoproliferative disorders
• Immune activation states

Abnormal CD25 expression patterns can help differentiate specific hematological disorders and guide further diagnostic evaluation.

Important Note

CD25 is rarely interpreted as a standalone marker. It is typically evaluated alongside other flow cytometry markers such as CD3, CD4, CD5, CD7, CD19, CD20, CD23, CD45, and additional lineage-specific markers to establish an accurate diagnosis.